$HDSN
HUDSON TECHNOLOGIES INC /NY

2022 Q1 Form 10-Q Financial Statement

#000141057822001262 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $84.34M $33.78M
YoY Change 149.67% -7.07%
Cost Of Revenue $38.52M $24.64M
YoY Change 56.32% -12.0%
Gross Profit $45.82M $9.138M
YoY Change 401.42% 9.44%
Gross Profit Margin 54.33% 27.05%
Selling, General & Admin $6.824M $6.748M
YoY Change 1.13% -7.18%
% of Gross Profit 14.89% 73.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $937.0K $847.0K
YoY Change 10.63% -52.94%
% of Gross Profit 2.04% 9.27%
Operating Expenses $7.522M $7.446M
YoY Change 1.02% -6.69%
Operating Profit $38.30M $1.692M
YoY Change 2163.48% 357.3%
Interest Expense $7.305M $2.817M
YoY Change 159.32% -185.11%
% of Operating Profit 19.07% 166.49%
Other Income/Expense, Net
YoY Change
Pretax Income $30.99M -$1.125M
YoY Change -2854.93% -61.86%
Income Tax $1.438M -$49.00K
% Of Pretax Income 4.64%
Net Earnings $29.56M -$1.076M
YoY Change -2846.75% -62.77%
Net Earnings / Revenue 35.04% -3.19%
Basic Earnings Per Share $0.66 -$0.02
Diluted Earnings Per Share $0.63 -$0.02
COMMON SHARES
Basic Shares Outstanding 44.78M 43.35M
Diluted Shares Outstanding 46.74M 43.35M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.152M $2.800M
YoY Change 84.0% -55.56%
Cash & Equivalents $5.152M $2.775M
Short-Term Investments
Other Short-Term Assets $7.680M $7.500M
YoY Change 2.4% 78.57%
Inventory $101.3M $47.60M
Prepaid Expenses
Receivables $38.18M $13.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $152.3M $71.80M
YoY Change 112.15% -14.73%
LONG-TERM ASSETS
Property, Plant & Equipment $19.18M $27.40M
YoY Change -29.99% -9.87%
Goodwill $47.80M
YoY Change
Intangibles $19.66M
YoY Change
Long-Term Investments
YoY Change
Other Assets $705.0K $100.0K
YoY Change 605.0%
Total Long-Term Assets $94.52M $97.70M
YoY Change -3.26% -5.6%
TOTAL ASSETS
Total Short-Term Assets $152.3M $71.80M
Total Long-Term Assets $94.52M $97.70M
Total Assets $246.8M $169.5M
YoY Change 45.63% -9.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.623M $9.000M
YoY Change -4.19% -21.74%
Accrued Expenses $33.99M $21.60M
YoY Change 57.34% 3.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.250M $17.70M
YoY Change -75.99% -31.4%
Total Short-Term Liabilities $46.86M $48.30M
YoY Change -2.98% -17.01%
LONG-TERM LIABILITIES
Long-Term Debt $91.53M $76.50M
YoY Change 19.64% -5.44%
Other Long-Term Liabilities $5.819M $3.400M
YoY Change 71.15% -33.33%
Total Long-Term Liabilities $91.53M $79.90M
YoY Change 14.55% -7.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.86M $48.30M
Total Long-Term Liabilities $91.53M $79.90M
Total Liabilities $145.9M $129.6M
YoY Change 12.61% -10.87%
SHAREHOLDERS EQUITY
Retained Earnings -$16.27M
YoY Change
Common Stock $449.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.9M $39.91M
YoY Change
Total Liabilities & Shareholders Equity $246.8M $169.5M
YoY Change 45.63% -9.7%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $29.56M -$1.076M
YoY Change -2846.75% -62.77%
Depreciation, Depletion And Amortization $937.0K $847.0K
YoY Change 10.63% -52.94%
Cash From Operating Activities $5.066M -$4.969M
YoY Change -201.95% 38.03%
INVESTING ACTIVITIES
Capital Expenditures $27.00K $290.0K
YoY Change -90.69% -252.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$27.00K -$290.0K
YoY Change -90.69% 52.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $71.00K
YoY Change
Debt Paid & Issued, Net $79.87M $1.314M
YoY Change 5978.08%
Cash From Financing Activities -3.379M 6.686M
YoY Change -150.54% -10.01%
NET CHANGE
Cash From Operating Activities 5.066M -4.969M
Cash From Investing Activities -27.00K -290.0K
Cash From Financing Activities -3.379M 6.686M
Net Change In Cash 1.660M 1.427M
YoY Change 16.33% -60.8%
FREE CASH FLOW
Cash From Operating Activities $5.066M -$4.969M
Capital Expenditures $27.00K $290.0K
Free Cash Flow $5.039M -$5.259M
YoY Change -195.82% 54.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7166000
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000925528
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44758925
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44909704
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-13412
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
CY2022Q1 dei City Area Code
CityAreaCode
845
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
735-6000
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
HDSN
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44909704
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5152000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3492000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38180000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14223000
CY2022Q1 us-gaap Inventory Net
InventoryNet
101314000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7680000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8090000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
152326000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
119949000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19183000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2022Q1 us-gaap Goodwill
Goodwill
47803000
CY2021Q4 us-gaap Goodwill
Goodwill
47803000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19659000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20357000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6803000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
705000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
710000
CY2022Q1 us-gaap Assets
Assets
246842000
CY2021Q4 us-gaap Assets
Assets
215715000
CY2022Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8623000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9623000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
31858000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30637000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2128000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3931000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5248000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
15000000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
46859000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64439000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1742000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1692000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5819000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91526000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q1 us-gaap Liabilities
Liabilities
145946000
CY2021Q4 us-gaap Liabilities
Liabilities
144776000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44909704
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44758925
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
449000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
448000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116713000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116312000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16266000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45821000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100896000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
246842000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215715000
CY2022Q1 us-gaap Revenues
Revenues
84338000
CY2021Q1 us-gaap Revenues
Revenues
33780000
CY2022Q1 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
38518000
CY2021Q1 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
24642000
CY2022Q1 us-gaap Gross Profit
GrossProfit
45820000
CY2021Q1 us-gaap Gross Profit
GrossProfit
9138000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6824000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6748000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7522000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
7446000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38298000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1692000
CY2022Q1 us-gaap Interest Expense
InterestExpense
7305000
CY2021Q1 us-gaap Interest Expense
InterestExpense
2817000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30993000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1125000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1438000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-49000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1076000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44779822
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43353213
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46736471
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43353213
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
361000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1076000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
39908000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
CY2022Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
72000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
403000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
29555000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100896000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1076000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
937000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
847000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
698000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
698000
CY2022Q1 hdsn Finance Lease Right Of Use Asset Amortization Reversal
FinanceLeaseRightOfUseAssetAmortizationReversal
1000
CY2021Q1 hdsn Finance Lease Right Of Use Asset Amortization Reversal
FinanceLeaseRightOfUseAssetAmortizationReversal
-4000
CY2022Q1 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-325000
CY2021Q1 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-763000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
656000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
403000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
361000
CY2022Q1 hdsn Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
289000
CY2021Q1 hdsn Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
277000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
51000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
59000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24613000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4165000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6845000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2390000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1222000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
998000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-335000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1628000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1822000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5066000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4969000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
290000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-290000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71000
CY2022Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-72000
CY2022Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
5186000
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
3326000
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-15000000
CY2021Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
8000000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
79866000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1314000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3379000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6686000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1660000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1427000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5152000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2775000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2203000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
2480000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-442000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
CY2022Q1 hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
CY2022Q1 hdsn Allocation Allowance Received By Company
AllocationAllowanceReceivedByCompany
3000000
CY2022Q1 hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the three-month period ended March 31, 2022 there was no customer accounting for 10% of the Company’s revenues. For the three-month period ended March 31, 2021 there was one customer accounting for 14% of the Company’s revenues and at March 31, 2021 there were $2.3 million of accounts receivable from this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2022Q1 hdsn Cylinder Deposit Value
CylinderDepositValue
12900000
CY2021 hdsn Cylinder Deposit Value
CylinderDepositValue
12300000
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8600000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q1 hdsn Net Operating Loss
NetOperatingLoss
20700000
CY2022Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
6000000.0
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9100000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29555000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1076000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44779822
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43353213
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1956649
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46736471
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43353213
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18483
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5589993
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used including potential impact of COVID-19 uncertainties. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and valuation </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of March 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2022Q1 us-gaap Inventory Gross
InventoryGross
106673000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
99828000
CY2022Q1 us-gaap Inventory Adjustments
InventoryAdjustments
5359000
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
5684000
CY2022Q1 us-gaap Inventory Net
InventoryNet
101314000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53791000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53854000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34608000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33761000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19183000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2022Q1 us-gaap Depreciation
Depreciation
900000
CY2021 us-gaap Depreciation
Depreciation
800000
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2278000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1632000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1427000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
900000
CY2022Q1 hdsn Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
2489000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8726000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1485000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7241000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5819000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7241000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0819
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
600000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Goodwill
Goodwill
47800000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13338000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19659000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12640000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20357000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2022Q1 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4791834
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2022Q1 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
338481
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
415478
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2540956
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.17
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13200000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8900000
CY2022Q1 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
400000
CY2021Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0.0
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
760392
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49050
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15000000
CY2022Q1 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
4250000
CY2021Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2022Q1 us-gaap Debt Current
DebtCurrent
4250000
CY2021Q4 us-gaap Debt Current
DebtCurrent
20248000
CY2022Q1 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
80750000
CY2021Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
74618000
CY2022Q1 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2021Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
0
CY2022Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4224000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1473000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91526000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
95776000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
93393000
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
4250000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4250000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
4250000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4250000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
83000000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
0
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
100000000

Files In Submission

Name View Source Status
0001410578-22-001262-index-headers.html Edgar Link pending
0001410578-22-001262-index.html Edgar Link pending
0001410578-22-001262.txt Edgar Link pending
0001410578-22-001262-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20220331.xsd Edgar Link pending
hdsn-20220331x10q.htm Edgar Link pending
hdsn-20220331x10q_htm.xml Edgar Link completed
hdsn-20220331xex31d1.htm Edgar Link pending
hdsn-20220331xex31d2.htm Edgar Link pending
hdsn-20220331xex32d1.htm Edgar Link pending
hdsn-20220331xex32d2.htm Edgar Link pending
hdsn-20220331_cal.xml Edgar Link unprocessable
hdsn-20220331_def.xml Edgar Link unprocessable
hdsn-20220331_lab.xml Edgar Link unprocessable
hdsn-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending